Universitario de Santiago, Spain Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Santiago de Compostela Spain (1495)

Organization Overview

First Clinical Trial
2005
NCT00334386
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

COMPLEXO HOSPITALARIO UNIVERSITARIO DE SANTIAGO | Hospital Clínico Universitario de Santiago | Hospital Clinico Universitario de Santiago, Santiago de Compostella, Spain | Hospital Universitario de Santiago | Hospital Universitario de Santiago, Santiago de Compostela, Spain | Manuel Taboada Muñiz | Maria Luz Couce Pico

Active Ingredients

Drugs in Phase 4 Trials (2)

dexamethasone (1 trial)

torsemide (demadex) (1 trial)

Drugs in Phase 3 Trials (2)

medium chain triglyceride (1 trial)

triheptanoin (Dojolvi) (1 trial)

Drugs in Phase 2 Trials (4)

belinostat (beleodaq) (1 trial)

gemcitabine (gemzar) (1 trial)

orteronel (1 trial)

paclitaxel (taxol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Lymphoma (Phase 2)

Lymphoma, T-Cell (Phase 2)

Lymphoma, T-Cell, Peripheral (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8